- currently enrolled in another investigational protocol to treat sars-cov-2 infection - known history of complement deficiency - active infection with, or history of, compllicated pneumococcal or neisseria meningitis infection or history of unexplained, recurrent infection, within the last 60 days prior to dosing.

- currently enrolled in another investigational protocol to treat sars-cov-2 infection - known history of complement deficiency - active infection with, or history of, compllicated pneumococcal or neisseria meningitis infection or history of unexplained, recurrent infection, within the last 60 days prior to dosing.